top of page
  • Er-Kim Public Relations

Er-Kim’s Cem Zorlular joins Turkish Government and Business Leaders on Official Visit to Gulf Countr

Istanbul, Türkiye – 26 July 2023 – Cem Zorlular, CEO of Er-Kim Pharmaceuticals, an international pharmaceutical company specializing in the commercialization of novel therapies, recently participated in President Tayyip Erdoğan’s three-stop tour of Persian Gulf states to strengthen diplomatic, trade and investment ties. The trip included business forums in Saudi Arabia, Qatar and the United Arab Emirates and took place from July 17-19.

Accompanying President Erdoğan were the Turkish Ministers of Foreign Affairs, Energy and Natural Resources, National Defense, Industry and Technology, and Trade. Zorlular was part of a delegation of business professionals operating in Turkey and the Gulf, representing various industries.

Zorlular, who is an executive board member of the Türkiye-Switzerland Business Council of DEiK, the Turkish Foreign Economic Relations Boards, said, “It was an honor to have been invited to take part in this important event in support of advancing strong relationships between these key regional partners. As a pharmaceutical representative, I am extremely pleased with the outcomes of these meetings, in which countries expressed significant interest in leveraging their mutual relationships to increase trade with other countries, and increasing investment in pharmaceutical R&D, particularly clinical trials.”

About Er-Kim Pharmaceuticals

Since 1981, Er-Kim has served as a trusted local partner to more than 40 of the world’s leading biopharmaceutical companies by offering flexible, sustainable, and compelling business models to commercialize new products in international markets. With broad experience in a wide range of therapeutic areas, Er-Kim has worked with well-established affiliates to deliver more than 70 innovative treatments to date, continuously expanding its global presence to deliver the best opportunities for partners and the latest standards of care to patients. For more information, please visit

70 views0 comments


Commenting has been turned off.
bottom of page